Welcome to our dedicated page for Q2 Holdings SEC filings (Ticker: QTWO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Q2 Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Q2 Holdings's regulatory disclosures and financial reporting.
QTWO reported Form 144 disclosures showing insider sales and a scheduled sale of performance stock units. The filing lists 1,343 performance stock units to be sold by the issuer on 03/09/2026. It also records prior sales by Himagiri Mukkamala: 1,793 common shares on 03/04/2026 for $89,207.00 and 3,024 common shares on 12/10/2025 for $96,046.00.
QTWO insiders reported proposed sales of common stock on Form 144. The filing lists a 03/04/2026 sale by Jonathan Breeden of 32,156 shares for $1,599,858.00 and a 03/03/2026 sale by Jonathan Price of 7,680 shares for $381,865.38. The notice also lists 8,680 performance stock units to be sold with an effective date of 03/09/2026.
Kirk Coleman reported the sale of Common stock under Rule 144. The notice lists sales on 12/10/2025 of 8,559 shares for $630,627.12, on 02/17/2026 of 12,917 shares for $68,757.91, on 03/03/2026 of 7,752 shares for $385,445.37, and on 03/04/2026 of 31,104 shares for $1,547,518.00.
Kimberly Rutledge reported sales of common stock under Rule 144. The filing lists three sales: 3,905 shares on 03/03/2026 for $194,156.60, 19,924 shares on 03/04/2026 for $991,219.00, and 20,948 shares on 03/05/2026 for $1,047,190.52. The cover references Common securities and a separate line for Performance Stock Units dated 03/09/2026. The trades are reported on Form 144 and list NYSE as the exchange.
Q2 Holdings, Inc. Chief People Officer Kimberly Anne Rutledge reported two open-market sales of Q2 common stock. On March 5, she sold 20,948 shares at a weighted average price of $51.66 per share, in multiple trades between $51.61 and $52.46. On March 9, she sold 4,340 shares at a weighted average price of $51.35 per share, in multiple trades between $51.34 and $51.70. The filing notes the activity was carried out under a Rule 10b5-1 trading plan adopted on September 12, 2025, and that the reported sale represents an issuer-mandated sale to cover tax withholding on vested restricted stock units, not a discretionary trade. Following these transactions, she directly held 83,738 Q2 common shares.
QTWO reports proposed insider sales and recent dispositions. The filing lists a proposed sale of 20,613 Performance Stock Units dated 03/09/2026. It also reports Matthew Flake sold 91,590 common shares on 03/04/2026 for $4,556,878.00 and 26,921 common shares on 03/03/2026 for $1,338,567.44.
Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported two open-market sales of common stock totaling 74,783 shares. On March 5, he sold 68,707 shares at a weighted average price of $51.73 per share, and on March 9, he sold 6,076 shares at a weighted average price of $51.35 per share. The prices reflect multiple trades within ranges of $50.63–$52.48 and $51.34–$51.70, respectively. These sales were effected under a Rule 10b5-l trading plan and represent issuer-mandated transactions to cover tax withholding on vested restricted stock units, not discretionary trades. Following the transactions, he held 84,236 shares of Q2 Holdings common stock directly.
John Breeden filed a Form 144 reporting proposed sales of Common stock. The notice lists three transactions: 03/03/2026 8,521 shares for $423,664.12, 03/04/2026 33,445 shares for $1,663,888.75, and 03/05/2026 68,707 shares for $3,434,662.93. The filing identifies the broker address at Morgan Stanley, 1585 Broadway, New York.
QTWO reported Form 144 filings showing insider sales by Michael Kerr. The notice lists three open-market dispositions: 1,550 shares for $77,066.00 on 03/03/2026, 7,157 shares for $356,060.75 on 03/04/2026, and 9,554 shares for $477,604.46 on 03/05/2026.
The filing also lists 2,821 Performance Stock Units identified under "Securities To Be Sold" with an action date of 03/09/2026.
Q2 Holdings, Inc. general counsel Michael S. Kerr reported selling a total of 12,375 shares of common stock in two open-market transactions, at weighted average prices of about $51–52 per share. Following the most recent sale, he holds 47,227 shares directly.
The filing notes that one sale was executed under a Rule 10b5-1 trading plan adopted on September 11, 2025, and that another sale was mandated by the issuer to cover tax withholding obligations arising from the vesting and settlement of restricted stock units, rather than representing a discretionary trade.